The results are shown in Figure 1C. Orai1 was commonly overexpressed at higher levels in glioma samples (WHO II and IV) and in all glioma cell lines compared with non-neoplastic brain tissues. This evidence concerns the gene ORAI1 and central nervous system cancer.